1. Nanoparticle therapy has potential to reprogram the immune system in type 1 diabetes COUR Pharmaceuticals is about to begin a phase 1b/2a study to assess a therapy for type …
Copyright MatchingDonors.com © 2026 All rights reserved.
Daily Diabetes News is published by MatchingDonors.com.